Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

152.00SEK
23 Jan 2019
Change (% chg)

0.00kr (+0.00%)
Prev Close
152.00kr
Open
150.00kr
Day's High
152.00kr
Day's Low
149.50kr
Volume
4,617
Avg. Vol
23,962
52-wk High
207.00kr
52-wk Low
103.50kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.711
Jun '18 0.00 0.059
Mar '18 0.00 -0.965
FY 2017 Dec '17 0.00 -1.543
Sep '17 0.00 -0.746
Jun '17 0.12 -2.249
Mar '17 0.12 -1.412
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-19 1 -29.40 -29.40 -29.40 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.49 33.71
P/E High - Last 5 Yrs. -- 45.03 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) 1,874.91 4.12 6.28
Price to Book (MRQ) 9.35 5.11 5.27
Price to Tangible Book (MRQ) 10.93 5.85 6.78
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions -- 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.31 9.73
Sales (TTM) vs TTM 1 Yr. Ago -- 4.15 5.88
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.66 45.05 47.26
EPS (TTM) vs TTM 1 Yr. Ago -185.52 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 8.95 2.98 3.08
LT Debt to Equity (MRQ) 0.00 8.86 11.39
Total Debt to Equity (MRQ) 0.00 12.91 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 59.50 53.65 53.79
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -11,130.50 -- --
EBITD - 5 Yr. Avg -- 17.95 12.87
Operating Margin (TTM) -11,130.50 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.31
Pre-Tax Margin (TTM) -11,083.25 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.61
Net Profit Margin (TTM) -11,083.25 11.08 3.31
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 959,737,456 844,196,423
Net Income/Employee (TTM) -- 113,812,018 100,059,031
Receivable Turnover (TTM) 0.75 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.35 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -42.09 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -42.09 16.30 15.99
Return on Equity - 5 Yr. Avg. -- 17.76 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -68,585.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Infant Bacterial Therapeutics AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 60.45 -- 98 22
13 Week 43.43 -- 94 39
26 Week 137.66 -- 98 33
52 Week 150.22 -- 95 9
YTD 222.73 -- 98 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.76%
# of Holders: 19
Total Shares Held: 3,662,149
3 Mo. Net Change: -47,903
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.